Centrosome alterations trigger a p53-response that arrest the cell cycle, indeed p53-proficient cells tolerate well variations of centrosomes copy number, while cancer cells defective in p53 frequently display centrosome anomalies (Lambrus et al., 2015). Here, TP53 is linked to cancer.